Bioextrax AB

Bioextrax AB

3.12
SEK
-0.08
(-2.50%)
-0.50EPS
Nov 20Next Earn

Important Dates

Bioextrax AB TEMP's next confirmed earnings release is scheduled for November 20, 2026.

Earnings Date11/20/2026

Share Statistics

As of June 30, 2026, Bioextrax AB TEMP has 40.74M shares outstanding.

Shares Outstanding40.74M

Financial Position

As of June 30, 2026, Bioextrax AB TEMP maintains a current ratio of 3.53, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.

Current Ratio3.53
Quick Ratio2.95
Interest Coverage-17,630.00

Financial Efficiency

Over the twelve months ended June 30, 2026, Bioextrax AB TEMP posted a negative return on equity (ROE) of -124.01, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -107.51, reflecting losses generated across the asset base.

Return on Equity (ROE)-124.01
Return on Assets (ROA)-107.51

Income Statement

SEK

Over the twelve months ended June 30, 2026, Bioextrax AB TEMP generated 545,000.00 in revenue and converted that into -18.57M in net income, yielding earnings per share of -0.50. EBITDA reached -17.63M, while operating income came in at -18.68M.

Revenue545,000.00
Gross Profit-514,000.00
Operating Income-18.68M
Pretax Income-18.57M
Net Income-18.57M
EBITDA-17.63M
EBIT-18.68M
Earnings Per Share (EPS)-0.50

Balance Sheet

SEK

These figures are as of June 30, 2026. Total book value stands at 11.98M, with working capital of 6.33M providing operational flexibility.

Cash & Cash Equivalents7.39M
Net Debt-7.39M
Equity (Book Value)11.98M
Book Value Per Share0.29
Working Capital6.33M

Cash Flow

SEK

Bioextrax AB TEMP produced -15.66M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -171,000.00 in capital expenditures, free cash flow totaled -15.83M - equivalent to -0.43 per share.

Operating Cash Flow-15.66M
Capital Expenditures-171,000.00
Free Cash Flow-15.83M
FCF Per Share-0.43

Margins

Over the twelve months ended June 30, 2026, Bioextrax AB TEMP posted a gross margin of -94.31, reflecting its pricing power and cost economics. The operating margin of -3,427.71 and net profit margin of -3,407.52 provide insight into operational efficiency.

Gross Margin-94.31
Operating Margin-3,427.71
Pretax Margin-3,407.52
Profit Margin-3,407.52
EBITDA Margin-3,234.86